Viewing StudyNCT06153537



Ignite Creation Date: 2024-05-06 @ 7:51 PM
Last Modification Date: 2024-10-26 @ 3:15 PM
Study NCT ID: NCT06153537
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2024-07-05
First Post: 2023-11-23

Brief Title: A Research Study in Saudi Arabia to Understand How the Dose Check App Used With Tresiba Treatment Helps to Control Blood Sugar Level
Sponsor:
Organization: Novo Nordisk AS

Study Design

Study Type: OBSERVATIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: False
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 175
Enrollment Type: ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Name
Cohort
Time Perspective List:

Clinical Trial Statuses

Name
101565
Who Masked List: